David Koditek

816 citations
8 papers · 254 · h-index 7

Impact in

    • Chronic Lymphocytic Leukemia Research
    • Axial and Atropisomeric Chirality Synthesis
    • Quinazolinone synthesis and applications

Papers in

    • PI3K/AKT/mTOR signaling in cancer 3
    • Signaling Pathways in Disease 1
    • TGF-β signaling in diseases 1
    • Protein Tyrosine Phosphatases 1
    • Histone Deacetylase Inhibitors Research 1
    • HIV/AIDS drug development and treatment 2

David Koditek

8 papers receiving 250 citations

Peers

David Koditek
Comparison fields: 5 of 53
  • Genetics 59
  • Organic Chemistry 96
  • Spectroscopy 47
  • Molecular Biology 167
  • Hematology 21
Replace Xinshan Kang with:
Xinshan Kang United States
Henrik Moebitz Switzerland
Pratistha Ranjitkar United States
Deheng Sun China
Georgi K. Kanev Netherlands
Oscar P. J. van Linden Netherlands
Martina Fitzek United Kingdom
Mickael Mogemark Sweden
Craig Titsch United States
Jennifer Treiberg United States
David Koditek relative to Xinshan Kang United States Xinshan Kang's profile →
Citations per field
00.5×5.2×
Xinshan Kang · 1×
Citations per year

Countries citing papers authored by David Koditek

Since Specialization
Citations

This map shows the geographic impact of David Koditek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Koditek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Koditek more than expected).

Fields of papers citing papers by David Koditek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Koditek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Koditek. The network helps show where David Koditek may publish in the future.

Co-authors

The 25 scholars most cited alongside David Koditek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Koditek Line = papers co-authored together David Koditek links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 2015119
2 201848
3 201727
4 200926
5 202013
6 20118
7 20157
8 20116

About David Koditek

David Koditek is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Hematology and Pharmacology, having authored 8 papers that have together received 254 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), HIV/AIDS drug development and treatment (2 papers), Signaling Pathways in Disease (1 paper), Molecular spectroscopy and chirality (1 paper), TGF-β signaling in diseases (1 paper), Protein Tyrosine Phosphatases (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Genetics (59 citations), Organic Chemistry (96 citations), Spectroscopy (47 citations), Molecular Biology (167 citations) and Hematology (21 citations). David Koditek has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Mary E. McGrath, John R. Somoza, Armando G. Villaseñor, Latesh Lad, Leanna Lagpacan, Brian E. Schultz, Melanie Wong, Giuseppe A. Papalia, Albert Liclican and Ruth Wang. Their work appears in journals such as SLAS DISCOVERY, Journal of Medicinal Chemistry, Biochemistry, ACS Medicinal Chemistry Letters and Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact